Negative Association Between Multiple Sclerosis Immunogenetic Profile and in Silico Immunogenicities of 12 Viruses

Overview

Journal Sci Rep

Specialty Science

Date 2023 Nov 1

PMID 37907711

Authors

Lisa M James

Apostolos P Georgopoulos

Affiliations

Soon will be listed here.

Abstract

Human Leukocyte Antigen (HLA) is involved in both multiple sclerosis (MS) and immune response to viruses. Here we investigated the virus-HLA immunogenicity (V-HLA) of 12 viruses implicated in MS with respect to 17 HLA Class I alleles positively associated to MS prevalence in 14 European countries. Overall, higher V-HLA immunogenicity was associated with smaller MS-HLA effect, with human herpes virus 3 (HHV3), JC human polyoma virus (JCV), HHV1, HHV4, HHV7, HHV5 showing the strongest association, followed by HHV8, HHV6A, and HHV6B (moderate association), and human endogenous retrovirus (HERV-W), HHV2, and human papilloma virus (HPV) (weakest association). These findings suggest that viruses with proteins of high HLA immunogenicity are eliminated more effectively and, consequently, less likely to be involved in MS.

References

Rice E, Thakolwiboon S, Avila M . Geographic heterogeneity in the association of varicella-zoster virus seropositivity and multiple sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord. 2021; 53:103024. DOI: 10.1016/j.msard.2021.103024. View

Dobson R, Giovannoni G . Multiple sclerosis - a review. Eur J Neurol. 2018; 26(1):27-40. DOI: 10.1111/ene.13819. View

Gough S, Simmonds M . The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action. Curr Genomics. 2009; 8(7):453-65. PMC: 2647156. DOI: 10.2174/138920207783591690. View

Fujinami R, von Herrath M, Christen U, Whitton J . Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev. 2006; 19(1):80-94. PMC: 1360274. DOI: 10.1128/CMR.19.1.80-94.2006. View

Sawcer S, Franklin R, Ban M . Multiple sclerosis genetics. Lancet Neurol. 2014; 13(7):700-9. DOI: 10.1016/S1474-4422(14)70041-9. View

Wang G, Wan H, Jian X, Li Y, Ouyang J, Tan X . INeo-Epp: A Novel T-Cell HLA Class-I Immunogenicity or Neoantigenic Epitope Prediction Method Based on Sequence-Related Amino Acid Features. Biomed Res Int. 2020; 2020:5798356. PMC: 7315274. DOI: 10.1155/2020/5798356. View

Agostini S, Mancuso R, Guerini F, DAlfonso S, Agliardi C, Hernis A . HLA alleles modulate EBV viral load in multiple sclerosis. J Transl Med. 2018; 16(1):80. PMC: 5870171. DOI: 10.1186/s12967-018-1450-6. View

Alfredsson L, Olsson T . Lifestyle and Environmental Factors in Multiple Sclerosis. Cold Spring Harb Perspect Med. 2018; 9(4). PMC: 6444694. DOI: 10.1101/cshperspect.a028944. View

Jakhmola S, Upadhyay A, Jain K, Mishra A, Jha H . Herpesviruses and the hidden links to Multiple Sclerosis neuropathology. J Neuroimmunol. 2021; 358:577636. DOI: 10.1016/j.jneuroim.2021.577636. View

10.

. Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18(3):269-285. PMC: 6372756. DOI: 10.1016/S1474-4422(18)30443-5. View

11.

Aloisi F, Giovannoni G, Salvetti M . Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy. Lancet Neurol. 2023; 22(4):338-349. DOI: 10.1016/S1474-4422(22)00471-9. View

12.

Manouchehrinia A, Tanasescu R, Kareem H, Jerca O, Jabeen F, Shafei R . Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis. J Neurovirol. 2017; 23(6):839-844. PMC: 5725504. DOI: 10.1007/s13365-017-0569-1. View

13.

Nora-Krukle Z, Chapenko S, Logina I, Millers A, Platkajis A, Murovska M . Human herpesvirus 6 and 7 reactivation and disease activity in multiple sclerosis. Medicina (Kaunas). 2011; 47(10):527-31. View

14.

Olsson T, Barcellos L, Alfredsson L . Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol. 2016; 13(1):25-36. DOI: 10.1038/nrneurol.2016.187. View

15.

Thakolwiboon S, Zhao-Fleming H, Karukote A, Pachariyanon P, Williams H, Avila M . Regional differences in the association of cytomegalovirus seropositivity and multiple sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord. 2020; 45:102393. DOI: 10.1016/j.msard.2020.102393. View

16.

Opsahl M, Kennedy P . Investigating the presence of human herpesvirus 7 and 8 in multiple sclerosis and normal control brain tissue. J Neurol Sci. 2005; 240(1-2):37-44. PMC: 7172428. DOI: 10.1016/j.jns.2005.08.014. View

17.

Hedstrom A, Lima Bomfim I, Barcellos L, Gianfrancesco M, Schaefer C, Kockum I . Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology. 2014; 82(10):865-72. PMC: 3959752. DOI: 10.1212/WNL.0000000000000203. View

18.

Charonis S, James L, Georgopoulos A . In silico assessment of binding affinities of three dementia-protective Human Leukocyte Antigen (HLA) alleles to nine human herpes virus antigens. Curr Res Transl Med. 2020; 68(4):211-216. DOI: 10.1016/j.retram.2020.06.002. View

19.

Bjornevik K, Cortese M, Healy B, Kuhle J, Mina M, Leng Y . Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022; 375(6578):296-301. DOI: 10.1126/science.abj8222. View

20.

Kakalacheva K, Munz C, Lunemann J . Viral triggers of multiple sclerosis. Biochim Biophys Acta. 2010; 1812(2):132-40. PMC: 7126972. DOI: 10.1016/j.bbadis.2010.06.012. View